The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This annual event provides an opportunity for FDA and CMS/CLIA representatives to respond to member questions and present the agency's current thinking on policies, regulations, guidance documents and inspection programs that are relevant to the oversight of blood and HCT/P programs. Questions for the session are submitted in advance to regulatory@aabb.org.
All relevant financial relationships have been mitigated.
Learning Objectives:
Evaluate existing practices to establish alignment with current regulatory requirements and recommendations.
Apply FDA's recommendations in recently issued guidance to industry.
Describe FDA's approach for blood and HCT/P policies, regulations and inspection programs.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
AM22-42-O: (On-Demand) Ask the FDA and CMS/CLIA (Enduring) Evaluation